Companies which are potentially undervalued and in an acceptable financial position.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
BNGA	Rp1,600.00	3.6%	-6.2%	Rp40.2t	Rp2,146.00	0.7	6.3%	9.7%	Banks
G92	S$1.86	1.6%	111.4%	S$1.6b	S$2.58	11.3	4.9%	2.7%	Energy
SPRC	฿7.05	-4.7%	28.2%	฿30.6b	฿8.49	3.3	-28.8%	6.4%	Energy
OU8	S$1.51	7.1%	-1.9%	S$1.3b	S$1.88	11.1	-0.3%	2.6%	Real Estate Management and Development
BMRI	Rp4,490.00	5.4%	-11.5%	Rp418.7t	Rp5,698.87	1.4	5.1%	10.4%	Banks
INDF	Rp6,750.00	8.0%	-16.9%	Rp59.3t	Rp8,812.50	5.4	10.0%	4.1%	Food, Beverage & Tobacco
OIL	₹417.05	-2.4%	-11.2%	₹678.4b	₹531.60	10.2	8.0%	2.8%	Energy
BTPS	Rp1,005.00	9.2%	-23.3%	Rp7.7t	Rp1,494.38	0.8	9.8%	3.9%	Banks
NSL	฿21.40	0.9%	-26.8%	฿6.4b	฿28.63	10.8	11.9%	4.9%	Food, Beverage & Tobacco
TESB	€20.60	5.0%	-19.7%	€1.2b	€25.50	0.4	69.5%	3.6%	Materials
PHM	€68.70	-17.6%	-15.3%	€1.2b	€106.11	14.8	31.7%	1.2%	Pharmaceuticals & Biotech
ARJO B	SEK 23.90	-2.4%	-25.5%	SEK 6.5b	SEK 30.00	18.5	21.3%	4.0%	Healthcare
SLGN	US$41.87	6.4%	-22.0%	US$4.4b	US$53.17	15.6	12.6%	2.0%	Materials
ADUS	US$93.87	0.8%	-18.5%	US$1.7b	US$132.69	17.2	11.1%	n/a	Healthcare
HUSQ B	SEK 38.67	-4.3%	-19.6%	SEK 22.1b	SEK 50.25	11.2	11.6%	3.2%	Capital Goods
VSTM	US$4.17	10.9%	-19.7%	US$352.4m	US$16.00	7.4	51.3%	n/a	Pharmaceuticals & Biotech
CABKA	€2.02	1.0%	3.1%	€49.9m	€3.28	0.3	105.5%	0%	Materials
SLDE	US$16.84	-1.5%	-16.8%	US$1.9b	US$25.20	3.9	-8.2%	n/a	Insurance
TRLV	US$9.45	-17.8%	161.0%	US$1.8b	US$19.42	1.6	124.5%	n/a	Pharmaceuticals & Biotech
XP	US$15.42	3.2%	-22.3%	US$8.1b	US$23.94	7.7	10.8%	1.3%	Diversified Financials
FLOC	US$22.56	-5.9%	28.5%	US$2.1b	US$31.56	22.1	37.4%	1.6%	Energy
ACIW	US$44.64	2.1%	-0.3%	US$4.6b	US$65.33	22.0	19.2%	n/a	Software
CEVI	SEK 141.20	12.1%	-24.3%	SEK 3.4b	SEK 179.00	25.1	15.0%	1.9%	Healthcare
FOUR	UK£37.30	2.8%	6.7%	UK£1.0b	UK£49.23	12.2	-5.3%	4.8%	Media

Healthy potentially undervalued